Login

Company overview with CEO | Phil Hartstein , President & CEO at FINJAN HOLDINGS, INC. 00:10:00

Share On Facebook Share On Twitter

Phil Hartstein is a President & CEO at FINJAN HOLDINGS, INC.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Iain Ross Executive Chairman, ReNeuron Group
00:10:00
Hot Chili's Low-Cost, High-Impact Copper Project: Key Insights and Future Plans
00:10:00
focused on early-stage companies servicing the advanced air mobility|Basil Yap,Co Founder,AeroX Ventures
00:10:00
Allgeier share: Even more boost for THE German IT price rocket? | Carl Georg Dürschmidt, CEO, Allgeier SEAEIX.N:GER
00:10:00
Comstock's Leadership Discusses YE 2023 Results and Strategic Platform Optimization | Corrado De Gasperis - Director, Executive Chairman, and Chief Executive Officer of Comstock Mining, Inc
00:10:00
Russia's Sovereign Risk, Banking Stability, and Investment Prospects
00:10:00
Volta Metals Unveils Promising Lithium Findings at Falcon West Drill Program | Kerem Usenmez - Director, President & CEO of Volta Metals
00:10:00
Harrison Metal invested in early-stage technology companies on behalf of their limited partners|Michael Dearing,Founder,Harrison Metal
00:10:00
Dedicated to financing the growth of companies operating in the space ecosystem|Rob Desborough,Managing Partner & CEO (Seraphim Space Camp),Seraphim Capital
00:10:00
Innovation in Middle Market Deals Through Strategic Partnerships and Cash Flow Management
00:10:00
INTERCORP LATAM CEO shares a testimony about NCR Corporation, with the video garnering 1.8K views in four years.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
El Al Israel Airlines Ltd. CEO Interview

© 2026 Nehu